|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.17 SEK | +3.16% |
|
+2.53% | -30.75% |
| Feb. 23 | Abliva AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 | CI |
| 2023 | Abliva AB Reaches Patient Enrollment Goal for Wave 1 of the FALCON Study | CI |
Read the article at biostock.se:
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/
https://news.cision.com/abliva/r/biostock--abliva-s-mission-to-become-mitochondrial-medicine-powerhouse,c3957091
(c) 2024 Cision. All rights reserved., source
| 1st Jan change | Capi. | |
|---|---|---|
| -30.75% | 20.28M | |
| -2.90% | 103B | |
| +1.27% | 95.28B | |
| +1.46% | 22.15B | |
| -16.10% | 21.02B | |
| -8.58% | 18.15B | |
| -38.74% | 16.73B | |
| -13.31% | 16.05B | |
| +4.83% | 13.68B | |
| +33.11% | 12.17B |
ABLIVA AB 
